Focal Healthcare was founded as a spin-off company out of the Centre for Imaging Technology Commercialization (CIMTEC). Focal is developing and marketing MRI (magnetic resonance imaging)-Ultrasound Fusion Biopsy and Therapy systems that have strong potential to become the new "gold standard" in prostate care by capitalizing on CIMTEC's intellectual property, as well as its extensive technology development and commercialization expertise in the medical imaging field.

The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation will fund 94 grants totaling $3.6 million in 2014, the largest amount ever awarded by the Foundation in a single year.

MedXT, an early-stage YCombinator company and cloud platform provider for medical imaging, announced its cost-effective, cloud-based mobile solution. It has been cleared by the U.S. Food and Drug Administration (FDA).

A new study by radiation oncologists at Mayo Clinic comparing the world’s literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. T

July 11, 2014 — On July 3, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would update payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule (PFS) on or after Jan. 1, 2015.

July 11, 2014 — The Texas Center for Proton Therapy received its new cyclotron this month, and the center is expected to treat its first patients in early 2016. The center is a collaboration of Texas Oncology, the US Oncology Network and McKesson Specialty Health.